| This article has been cited by |
| 1 | Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources | |
| Likeng Liang,Jifa Hu,Gang Sun,Na Hong,Ge Wu,Yuejun He,Yong Li,Tianyong Hao,Li Liu,Mengchun Gong |
| Drug Safety.2022;45(5)511 |
| [DOI] |
|
| 2 | Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources | |
| Joel Fossouo,Rachael Mcdonald,Nilmini Wickramasinghe |
| Drug Safety.2022;45(5)187 |
| [DOI] |
|
| 3 | Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources | |
| Satabdi Chatterjee,Rajender R. Aparasu |
| Drug Safety.2022;45(5)1 |
| [DOI] |
|
| 4 | Pharmacovigilance and the digital world in Italy: presentation of the results of a national survey | |
| Lisa Stagi,Ilenia Bocchi,Salvatore Bianco,Grazia Sirizzotti,Daniela Bernardini,Valentina Calderazzo,Giacomo Pirisino,Ilaria Grisoni,Silvia Romano |
| Therapeutic Advances in Drug Safety.2021;12(5)204209862098599 |
| [DOI] |
|
| 5 | Pharmacovigilance of herbal medicines: Concerns and future prospects | |
| Abinash Choudhury,Preet Amol Singh,Neha Bajwa,Subhransu Dash,Preeti Bisht |
| Journal of Ethnopharmacology.2023;309(5)116383 |
| [DOI] |
|
| 6 | Structured content and data management—enhancing acceleration in drug development through efficiency in data exchange | |
| Jill Beierle,Marquerita Algorri,Marisol Cortés,Nina S. Cauchon,Andrew Lennard,J. Paul Kirwan,Shirley Oghamian,Michael J. Abernathy |
| AAPS Open.2023;9(1)116383 |
| [DOI] |
|
| 7 | ASPECTS OF UTILIZATION AND LIMITATIONS OF ARTIFICIAL INTELLIGENCE IN DRUG SAFETY | |
| SUJITH T,CHAKRADHAR T,SRAVANI MARPAKA,SOWMINI K |
| Asian Journal of Pharmaceutical and Clinical Research.2021;9(1)34 |
| [DOI] |
|
| 8 | ASPECTS OF UTILIZATION AND LIMITATIONS OF ARTIFICIAL INTELLIGENCE IN DRUG SAFETY | |
| Prashant Pokhriyal,Vivek P. Chavda,Mili Pathak |
| Asian Journal of Pharmaceutical and Clinical Research.2023;9(1)401 |
| [DOI] |
|
| 9 | Navigating a transforming landscape: the evolving role of pharmacovigilance physicians in drug development and implications for future challenges and training requirements | |
| Tarek A. Hammad,Salman Afsar,Herve Le-Louet,Veronique F. Kugener |
| Frontiers in Drug Safety and Regulation.2023;3(1)401 |
| [DOI] |
|
| 10 | Perspectives of Artificial Intelligence (AI) in Health Care Management:
Prospect and Protest | |
| Narmatha Sasi Prakash,Lakshmi Chandran,Madhana Kumar Sivakumar,Ankul Singh Suresh Pratap Singh |
| The Chinese Journal of Artificial Intelligence.2022;1(2)401 |
| [DOI] |
|
